Aim: Mangifera indica is a plant with several phytoconstituents which accounts for its tradopharmacological uses such as treatment of syphilis, anemia, diabetes, diarrhea, mouth wound, ulcer, leucorrhea, fever, liver diseases, urinary tract infection, asthma, rheumatism, cough, colon cancer and dysentery. The present study was aimed at identifying and characterizing some of the active principles from root of the plant.
INTRODUCTION
Medicinal plants are a rich source of drugs that form a vital component in traditional and modern medicines as well, serve as pharmaceutical intermediates in drug production. This accounts for the usefulness of plants in the treatment of diseases and play vital roles in the world's pharmaceuticals due to chemical substances found in them [1] . Mangifera indica belong to the genus Mangifera of the family Anacardiaceae, commonly known as mango family. The genus Mangifera consists of about 30 species of tropical edible fruit trees in the flowering plant from the family Anacardiaceae with Mangifera indica being the most common species. Taxonomically, Mangifera indica belongs to the kingdom-plantae, class-Mangoliopsida, phylumMangoliophyta, order-Sapindales, familyAnacardiaceae, genus-Mangifera and speciesIndica [2] . Mangifera indica plant is an evergreen broad canopy tree which grows to a height of 8-20 m, brown-gray colour thick bark and superficially cracked [3] . Leaves are 10-15 cm in length with variable sizes. Mangifera indica species have a long history of medicinal use in the treatment of syphilis, anemia, diabetes, diarrhea, mouth wound, ulcer, leucorrhea, fever, liver diseases, urinary tract infection, asthma, rheumatism, cough, colon cancer and dysentery. Other trado-medicinal uses of the plant root have been reported [4] . Plant sterols have been reported for their antitumor effects and cholesterol lowering [5] . Thus, this study investigated the root of Mangifera indica with a view to identifying some of the bioactive principles responsible for its ethnomedical applications. . Melting points (Mp) were determined with a SMPI stuart Scientific melting point apparatus. Column chromatography was performed on silica gel 60H, 200-400 mesh. Thin layer chromatography (TLC) was performed on pre-coated aluminum backed (silicycle), Tlc plate silica gel (0.2 mm) and Visualized by spraying with concentrated sulfuric acid and then heated to 105°C
MATERIALS AND METHODS

Plant Collections
General Experimental Procedure
Sample Extraction
Pulverized Mangifera indica root (1 kg) was sequentially extracted using Soxhlet (n-hexane and ethyl acetate). Excess solvent was removed under reduced pressure and residue stored in the refrigerator. The ethyl acetate extract was dissolved in n-hexane and chloroform (1:1), and refluxed for three hours then filtered.
Chromatographic Separation
The filtrate was subjected to column chromatography using silica gel as stationary phase. The solvent system consisted of n-hexane in combination with increasing percentage of ethyl acetate. About 35 mL fractions were collected by gradient elution technique and elutes were monitored using thin layer chromatography using 30:70 of ethyl acetate and hexane solvent ratio. The fractions showing similar R f value after visualizing by UVlamp were pooled. Obtained fractions were verified with thin layer chromatography by spraying with anisaldehyde-Sulphuric acid and the plate the purple colour spots were confirmed as sterols. Fractions corresponding to R f values were pooled, washed with acetone and subjected to TLC with hexane-ethyl acetate 8:2 (V/V). Fractions 18-24 (18.9 mg) were discovered to have crystals. The crystals were washed separately and repeated with Hexane (40 ml) TLC with hexane and dichloromethane (1:2) gave a single spot with Rf 0.64. The purified fraction was labeled NPJ-68. This was confirmed using Salkowski reaction and LeibermannBurchard reaction as described by [6] .
Spectroscopic Characterization
Different spectroscopic methods such as FTIR, LCMS, MP, 1 H-NMR and 13 C-NMR were used to elucidate the structure of stigmasterol andsitosterol. The spectra ( 1 H, 13 C, 2D NMR were recorded using CDCl 3 as solvent on a Bruker Avance 3 spectrophotometer at University of Strathclyde, Glasgow, Scotland, United Kingdom.
Antimicrobial Screening
The antimicrobial activities of the isolated compound from the plant under investigation were determined using some animal and plant pathogens. All microorganisms were checked for purity and maintained in slants for agar [7] .
Cultivation and Standardization of Test Organism
A loop full of test organisms were taken from the agar slant and sub culture into test tubes containing sterile nutrient agar for bacterian and subourand dextrose medium (20 ml) for for fungi, the test tubes were incubated for 48hrs at 37°C. The broth cultures were standardized using sterile normal saline to obtain a density of 106 cfu/mL for bacteria. A sporulated test fungal spore was harvested with 0.05% Tween80 in sterile normal and standardized to 106 spores/mL.
Antimicrobial Profile (Sensitivity test)
0.002 mg of the compound was weighed and dissolved in 10 mls of DMSO obtain a concentration of 20 µg/ml. Diffusion method was used for screening the compound. Mueller Hinton agar sabouraud dextrose agar was the media used as the growth media for the microbes. The media were prepared according to the manufacturer's instructions sterilized at 121°C for 15 minutes, poured into sterile petri dishes and were allowed to cool and solidify. The Mueller Hinton agar was seeded with 0.1 ml of the standard inoculum of the test bacteria while the sabouraud dextrose agar was seeded with 0.1 ml of the test fungi. The inoculum was spread evenly over the surface of the medium by the use of a sterile swab. By the use of a standard sterile cork borer of 6mm in diameters, well was cut at the centre of each inoculated media. 0.1 ml of the solution of the compound of the concentration of 20 µg/ml was then introduced into the well on the inoculated media. Incubation was made at 37°C for 24hrs for the bacteria and at 30°C for 1-7 days for the fungi after which the plates of the media were observed for the zone of inhibition of growth, the zone was measured with a transparent ruler and the result recorded in millimetres.
Determination of Minimum Inhibitory Concentration (MIC)
The minimum inhibition concentration of the compound was determined using the broth dilution method. Mueller Hinton broth and sabouraud dextrose broth were prepared, 10 mLs of the broth was dispensed into test tubes and were sterilized at 121°c for 15 minutes, the broth was allowed to cool. cfu/ml. Two-fold seriel dilution of the compound was done in the sterile broth to obtain the concentrations of 20 µg/m/l, 10 µg/ml, 5 µg/ml, 2.5 µg/ml and 1.25 µg/ml. the initial concentration was obtained by dissolving 0.002 mg of the compound in 10 mls of the sterile broth.Having obtained the different concentrations of the compound in the sterile broth, 0.1 ml of the test microbe in the normal saline was then inoculated into the different concentrations incubation was made at 37°C for 24 hours for the bacteria and at 30°C for 1-7 days for the fungi, after which the test tubes of the broth were observed for turbidity (growth) the lowest concentration of the compound in the sterile broth which shows no turbidity was recorded as the minimum inhibition concentration (MIC).
Determination of Minimum Bactericidal/ Fungicidal Concentration (MBC/MFC)
MBC/MFC was carried out to determine whether the test microbes were killed or only their growth inhibition. Mueller agar and sabouraud dextrose agar were prepared, sterilized at 121°C for 15 minutes, poured into sterile petri dishes and were allowed to cool and solidify. The contents of the MIC in the serial dilutions were then sub-cultured onto the prepared media, the bacteria were subcultured onto the Mueller agar while the fungi were sub-cultured onto sabouraud dextrose agar, incubation was made at 37°C for 24 hours for the bacteria and at 30°C for 1-7 days for the fungi, after which the plates of the media were observed for colony growth MBC/MFC were the plates with lowest concentration of the compound without colony growth. Results were recorded after 24 hours [8] .
RESULTS AND DISCUSSION
The results of the spectroscopic characterization and antimicrobial activities of stigmasterol and β-sitosterol from Mangifera indica root are reported in Tables 1 and 2 , 3, 4 and 5 respectively.
Characterization of Compound NPJ 68 as a Mixture of Stigmasterol and β-Sitosterol
Compound NPJ 68 was obtained as a white crystalline solid. Analysis of the C-NMR spectrum indicated resonance at c 71.97 attributed to C-3. The hydroxyl group was placed at C-3 due to the correlations observed in the HMBC spectrum the H-3 and carbon resonance ( 146.93 and 121.86) ascribable to double bonds at C-5 and C-6 [10] . Signals observed at 142.92 and 129.87 corresponds to C-22 and C-23. The signals relating to the olefinic protons H-22, H-23 and H-6 observed from the 1 HNMR spectrum suggested both stigmasterol and sitosterol in an equal proportion in the mixture, this was confirmed by their integration as follows: a doublet of doublet observed at 3.52 attributed to H-3 for a mixture of stigmaterol-sitosterol was integrated for 2. The proton at H 5.35 corresponding to H-6 for sitosterol and stigmasterol. While H-22 and H-23 of stigmasterol with signals at 4.17 and 5.35 were integrated for 1 proton each. Therefore, the mixture is in a ratio of 1:1 stigmasterol-sitosterol. The relative configuration of compound NPJ 68 was that expected for a steroidal derivative as it was confirmed by a detailed analysis of COSY and HMBC experiments. In the HSQC spectrum, a single bond correlation was shown by H-20 ( [13] . Antioxidant, anti-inflammatory, analgesic and anthelmintic activity. Its hypoglycemic and hypercholesterolemic property as well as its usage as precursor in the synthesis of steroidal drugs has been reported [14] . Table 2 shows the activity of the isolated compound on the selected animal pathoges.The compound has inhibition effect against the microbes as it was sensitive to Vancomycine resist enterococci, staphylococcus aureus, Eucherichia coli and Pseudomona aeruginosa but was resistance to methicillin resist staph aureus and salmonella typhi. [15] reported the ability of Anogeissus leiocarpus against some pathogenic microorganisms such as S. aureus, Klebseilla species, C. albicans, E. coli. The table also shows the zone of inhibition of the isolated compounds against the clinical isolates. The zones of inhibition range from 28-31 mm which is a strong indication of clearance zone by the compounds. This is an evidence that the root of Mangifera indica can be used in the treatment of diseases caused by these pathogens. This is in line with the claims of other researchers that the plant has antimicrobial activity against many pathogens and thus a confirmation of its traditional medical uses. Table 3 shows the antifungal activities of the isolated compounds against some plant pathogens. The result shows that Aspergillus fumigates, Aspargillus nigre, Coniophora puteana, Fibrophoria vaillentii, Fusarium proliforatum, Rhizopus sp, Sclerotium rofsii and Serpula lacrymans were sensitive with zone of inhibition ranging from 27-31 mm, while,Aspergillus flavus, Fomitopsis pinicola, Fusarium oxysporum were resistant to NPJ-68. This showed that these compounds and the plant Under investigation could be a useful precursor for the production of fungicides which could be used in the management of diseases caused by these tested pathogens. Tables 4 and 5 . The MIC varied from 2.5-5 g/mL in this study and is lower than that reported [16] . Thus, its inhibition potency against the pathogens account for the various tradomedicinal uses of the plant.
CONCLUSION
The study investigated the isolation and characterization of mixture of stigmasterol and β-sitosterol from Mangifera indica root using physical and spectroscopic methods. The isolated compounds exhibited appreciable antimicrobial activities against some microbes, therefore, confirming many ethno-medical uses of the plant. This plant could be a potential candidate for drug development for the treatment of several diseases caused by these pathogens tested in this study for both man and plants.
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